Recurrent variations in DNA methylation in human pluripotent stem cells and their differentiated derivatives.

[1]  K. Eggan,et al.  Erosion of dosage compensation impacts human iPSC disease modeling. , 2012, Cell stem cell.

[2]  Wei Huang,et al.  Insulin‐like growth factor‐2 (IGF2) loss of imprinting marks a field defect within human prostates containing cancer , 2011, The Prostate.

[3]  H. Vaziri,et al.  Suppression of the Imprinted Gene NNAT and X-Chromosome Gene Activation in Isogenic Human iPS Cells , 2011, PloS one.

[4]  O. Dreesen,et al.  Unexpected X chromosome skewing during culture and reprogramming of human somatic cells can be alleviated by exogenous telomerase. , 2011, Cell stem cell.

[5]  M. Esteller,et al.  Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome , 2011, Epigenetics.

[6]  Jeannie T. Lee,et al.  X-chromosome epigenetic reprogramming in pluripotent stem cells via noncoding genes. , 2011, Seminars in cell & developmental biology.

[7]  L. Lefebvre,et al.  Developmental regulation of somatic imprints. , 2011, Differentiation; research in biological diversity.

[8]  Thomas Vierbuchen,et al.  Induction of human neuronal cells by defined transcription factors , 2011, Nature.

[9]  A. Nagy,et al.  Human Induced Pluripotent Stem Cells: The Past, Present, and Future , 2011, Clinical pharmacology and therapeutics.

[10]  Jun S. Song,et al.  Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells , 2011, Nature Cell Biology.

[11]  R. Stewart,et al.  Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells , 2011, Nature.

[12]  D. Pinto,et al.  A novel approach identifies new differentially methylated regions (DMRs) associated with imprinted genes. , 2011, Genome research.

[13]  Bernhard M. Schuldt,et al.  A bioinformatic assay for pluripotency in human cells , 2011, Nature Methods.

[14]  Michael J. Ziller,et al.  Reference Maps of Human ES and iPS Cell Variation Enable High-Throughput Characterization of Pluripotent Cell Lines , 2011, Cell.

[15]  E. Kirkness,et al.  Somatic coding mutations in human induced pluripotent stem cells , 2011, Nature.

[16]  Julie V. Harness,et al.  Equivalence of Conventionally-Derived and Parthenote-Derived Human Embryonic Stem Cells , 2011, PloS one.

[17]  Julie V. Harness,et al.  Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. , 2011, Cell stem cell.

[18]  P. Stanier,et al.  The effects of culture on genomic imprinting profiles in human embryonic and fetal mesenchymal stem cells , 2011, Epigenetics.

[19]  S. Uribe-Lewis,et al.  Molecular mechanisms of genomic imprinting and clinical implications for cancer , 2011, Expert Reviews in Molecular Medicine.

[20]  J. Segars,et al.  Imprinting disorders and assisted reproductive technology , 2010, Current opinion in endocrinology, diabetes, and obesity.

[21]  Fred H. Gage,et al.  A Model for Neural Development and Treatment of Rett Syndrome Using Human Induced Pluripotent Stem Cells , 2010, Cell.

[22]  K. Plath,et al.  Female human iPSCs retain an inactive X chromosome. , 2010, Cell stem cell.

[23]  Tamar Dvash,et al.  Variations of X Chromosome Inactivation Occur in Early Passages of Female Human Embryonic Stem Cells , 2010, PloS one.

[24]  G. Daley,et al.  Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells. , 2010, Cell stem cell.

[25]  C. Lengner,et al.  Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs , 2010, Proceedings of the National Academy of Sciences.

[26]  Cory Y. McLean,et al.  GREAT improves functional interpretation of cis-regulatory regions , 2010, Nature Biotechnology.

[27]  Jennifer A. Erwin,et al.  Derivation of Pre-X Inactivation Human Embryonic Stem Cells under Physiological Oxygen Concentrations , 2010, Cell.

[28]  Kwang-Soo Kim,et al.  Hemangioblastic Derivatives from Human Induced Pluripotent Stem Cells Exhibit Limited Expansion and Early Senescence , 2010, Stem cells.

[29]  Chia-Lin Wei,et al.  Dynamic changes in the human methylome during differentiation. , 2010, Genome research.

[30]  Gabriel Kolle,et al.  A Continuum of Cell States Spans Pluripotency and Lineage Commitment in Human Embryonic Stem Cells , 2009, PloS one.

[31]  Fred H. Gage,et al.  Transcriptional Signature and Memory Retention of Human-Induced Pluripotent Stem Cells , 2009, PloS one.

[32]  Mike J. Mason,et al.  Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. , 2009, Cell stem cell.

[33]  J. Lawrence,et al.  X‐inactivation reveals epigenetic anomalies in most hESC but identifies sublines that initiate as expected , 2008, Journal of cellular physiology.

[34]  R. Rowntree,et al.  X-chromosome inactivation and epigenetic fluidity in human embryonic stem cells , 2008, Proceedings of the National Academy of Sciences.

[35]  M. Pellegrini,et al.  X-inactivation in female human embryonic stem cells is in a nonrandom pattern and prone to epigenetic alterations , 2008, Proceedings of the National Academy of Sciences.

[36]  C. Mummery,et al.  Gene-specific vulnerability to imprinting variability in human embryonic stem cell lines. , 2007, Genome research.

[37]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[38]  R. Pedersen,et al.  Status of genomic imprinting in human embryonic stem cells as revealed by a large cohort of independently derived and maintained lines. , 2007, Human molecular genetics.

[39]  G. Churchill,et al.  Characterization of human embryonic stem cell lines by the International Stem Cell Initiative , 2007, Nature Biotechnology.

[40]  Yue-zhong Wu,et al.  Restriction landmark genome scanning identifies culture-induced DNA methylation instability in the human embryonic stem cell epigenome. , 2007, Human molecular genetics.

[41]  R. Jirtle,et al.  Metastable Epialleles, Imprinting, and the Fetal Origins of Adult Diseases , 2007, Pediatric Research.

[42]  Jian-Bing Fan,et al.  Human embryonic stem cells have a unique epigenetic signature. , 2006, Genome research.

[43]  N. Jareborg,et al.  Human QKI, a potential regulator of mRNA expression of human oligodendrocyte-related genes involved in schizophrenia. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[44]  J. Lawrence,et al.  X‐Inactivation Status Varies in Human Embryonic Stem Cell Lines , 2005, Stem cells.

[45]  M. Carpenter,et al.  Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation , 2005, Glia.

[46]  Philippe Rigault,et al.  A novel, high-performance random array platform for quantitative gene expression profiling. , 2004, Genome research.

[47]  U. Suter,et al.  The Protooncogene Ski Controls Schwann Cell Proliferation and Myelination , 2004, Neuron.

[48]  B. Migeon,et al.  Species differences in TSIX/Tsix reveal the roles of these genes in X-chromosome inactivation. , 2002, American journal of human genetics.

[49]  David J. Anderson,et al.  The bHLH Transcription Factors OLIG2 and OLIG1 Couple Neuronal and Glial Subtype Specification , 2002, Cell.

[50]  J. Thomson,et al.  Embryonic stem cell lines derived from human blastocysts. , 1998, Science.